Plain-English translation of NCT06748703 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are investigating whether CPAP (a breathing device used at night) can help prevent or reduce optic nerve damage in people with obstructive sleep apnea. Sleep apnea causes repeated drops in oxygen levels during the night, which may starve the optic nerve of blood and oxygen. This study will measure whether using CPAP treatment for 3 months improves blood flow to the eye and protects vision.
Many sleep apnea patients develop optic nerve damage that can lead to blindness, but doctors often miss this because it looks like a different eye condition. Researchers want to understand whether treating sleep apnea with CPAP can actually prevent or reverse this eye nerve damage, which would help protect patients' vision.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital twice: at the start and after 3 months of CPAP treatment. At each visit, you'll have a sleep study (where you sleep while monitors measure your breathing and oxygen levels) and eye exams (which measure blood flow in your optic nerve, vision, eye pressure, and other eye health markers). Between visits, you'll use the CPAP machine every night at home, which gently pushes air into your airway to keep it open while you sleep.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China